Center-Authored Papers

Filters: Author is Gilbert, Peter B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Aiyegbo MS, Shmelkov E, Dominguez L, Goger M, Battacharya S, Decamp AC, Gilbert PB, Berman PW, Cardozo T.  2017.  Peptide Targeted by Human Antibodies Associated with HIV Vaccine-Associated Protection Assumes a Dynamic α-Helical Structure.. PloS one. 12(1):e0170530. Abstract
B
Benkeser D, Carone M, Gilbert PB.  2017.  Improved estimation of the cumulative incidence of rare outcomes.. Statistics in medicine. Abstract
Boeckh MJ, Gilbert PB.  2016.  Search continues for a CMV vaccine for transplant recipients.. The Lancet. Haematology. 3(2):e58-9.
Bonsignori M, Pollara J, Moody AM, Alpert MD, Chen X, Hwang K-K, Gilbert PB, Huang Y, Gurley TC, Kozink DM et al..  2012.  Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family.. Journal of virology. 86(21):11521-32. Abstract
Buchbinder SP, Grunenberg NA, Sanchez BJ, Seaton KE, Ferrari G, Moody AM, Frahm N, Montefiori DC, Hay CM, Goepfert PA et al..  2017.  Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.. PloS one. 12(7):e0179597. Abstract
Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, Gilbert PB, Lama JR, Marmor M, del Rio C et al..  2008.  Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.. Lancet. 372(9653):1881-93. Abstract
C
Churchyard G, Mlisana K, Karuna S, Williamson A-L, Williamson C, Morris L, Tomaras GD, De Rosa SC, Gilbert PB, Gu N et al..  2016.  Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants.. PloS one. 11(9):e0161753. Abstract
Corey L, Gilbert PB, Tomaras GD, Haynes BF, Pantaleo G, Fauci AS.  2015.  Immune correlates of vaccine protection against HIV-1 acquisition.. Science translational medicine. 7(310):310rv7. Abstract
Corey L, Nabel GJ, Dieffenbach C, Gilbert PB, Haynes BF, Johnston M, Kublin J, Lane CH, Pantaleo G, Picker LJ et al..  2011.  HIV-1 vaccines and adaptive trial designs.. Science translational medicine. 3(79):79ps13. Abstract
D
Dai JY, Gilbert PB, Hughes JP, Brown ER.  2013.  Estimating the Efficacy of Preexposure Prophylaxis for HIV Prevention Among Participants With a Threshold Level of Drug Concentration.. American journal of epidemiology. 177(3):256-63. Abstract
Dai JY, Gilbert PB, Mâsse BR.  2012.  Partially Hidden Markov Model for Time-Varying Principal Stratification in HIV Prevention Trials. Journal of the American Statistical Association. 107(497):52-65.
Dai JY, Li SS, Gilbert PB.  2013.  Case-only method for cause-specific hazards models with application to assessing differential vaccine efficacy by viral and host genetics.. Biostatistics (Oxford, England). Abstract
E
Edlefsen PT, Rolland M, Hertz T, Tovanabutra S, Gartland AJ, Decamp AC, Magaret CA, Ahmed H, Gottardo R, Juraska M et al..  2015.  Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial.. PLoS computational biology. 11(2):e1003973. Abstract
Edlefsen PT, Gilbert PB, Rolland M.  2013.  Sieve analysis in HIV-1 vaccine efficacy trials.. Current opinion in HIV and AIDS. Abstract
F
Fiore-Gartland A, Kullman N, Decamp AC, Clenaghan G, Yang W, Magaret CA, Edlefsen PT, Gilbert PB.  2017.  SieveSifter: a web-based tool for visualizing the sieve analyses of HIV-1 vaccine efficacy trials.. Bioinformatics (Oxford, England). 33(15):2386-2388. Abstract
Fiore-Gartland A, Manso BA, Friedrich DP, Gabriel EE, Finak G, Moodie Z, Hertz T, De Rosa SC, Frahm N, Gilbert PB et al..  2016.  Pooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine Efficacy Trials.. PloS one. 11(2):e0147812. Abstract
Fitzgerald DW, Janes H, Robertson M, Coombs R, Frank I, Gilbert PB, Loufty M, Mehrotra D, Duerr A.  2011.  An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study).. The Journal of infectious diseases. 203(6):765-72. Abstract
Fong Y, Di C, Huang Y, Gilbert PB.  2016.  Model-robust inference for continuous threshold regression models.. Biometrics. Abstract
Fu R, Gilbert PB.  2016.  Joint modeling of longitudinal and survival data with the Cox model and two-phase sampling.. Lifetime data analysis. Abstract
Fuchs JD, Bart P-A, Frahm N, Morgan C, Gilbert PB, Kochar N, De Rosa SC, Tomaras GD, Wagner TM, Baden LR et al..  2015.  Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals.. Journal of AIDS & clinical research. 6(5) Abstract
G
Gabriel EE, Gilbert PB.  2013.  Evaluating principal surrogate endpoints with time-to-event data accounting for time-varying treatment efficacy.. Biostatistics (Oxford, England). Abstract
Gartland AJ, Li S, McNevin J, Tomaras GD, Gottardo R, Janes H, Fong Y, Morris D, Geraghty DE, Kijak GH et al..  2014.  Analysis of HLAA*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial.. Journal of virology. Abstract
Gilbert PB, Gabriel EE, Miao X, Li X, Su S-C, Parrino J, Chan ISF.  2014.  Fold rise in Antibody Titers by gpELISA is an Excellent Correlate of Protection for a Herpes Zoster Vaccine, Demonstrated via the Vaccine Efficacy Curve.. The Journal of infectious diseases. Abstract
Gilbert PB, Berger JO, Stablein D, Becker S, Essex M, Hammer SM, Kim JH, Degruttola VG.  2011.  Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials.. The Journal of infectious diseases. 203(7):969-75. Abstract
Gilbert PB, Yu X, Rotnitzky A.  2013.  Optimal auxiliary-covariate-based two-phase sampling design for semiparametric efficient estimation of a mean or mean difference, with application to clinical trials.. Statistics in medicine. Abstract